Manufacturer of Controlled Substances; Notice of Registration, 9614 [2010-4401]
Download as PDF
<![CDATA[
9614
Federal Register / Vol. 75, No. 41 / Wednesday, March 3, 2010 / Notices
Dated: February 24, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration
mstockstill on DSKH9S0YB1PROD with NOTICES
By Notice dated October 16, 2009, and
published in the Federal Register on
October 28, 2009 (74 FR 55584), Clinical
Supplies Management, 342 42nd Street
South, Fargo, North Dakota 58103, made
application to the Drug Enforcement
Administration (DEA) to be registered as
an importer of Poppy Straw Concentrate
(9670), a basic class of controlled
substance listed in schedule II.
The company plans to import an
ointment for the treatment of wounds
which contains trace amounts of
controlled substances normally found in
poppy straw concentrate which will be
packaged and labeled for clinical trials.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and § 952(a),
and determined that the registration of
Clinical Supplies Management to import
the basic class of controlled substance is
consistent with the public interest, and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971, at
this time. DEA has investigated Clinical
Supplies Management to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and § 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic class of controlled substance
listed.
Dated: February 24, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2010–4439 Filed 3–2–10; 8:45 am]
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration
[FR Doc. 2010–4440 Filed 3–2–10; 8:45 am]
DEPARTMENT OF JUSTICE
Manufacturer of Controlled
Substances; Notice of Registration
By Notice dated October 30, 2009, and
published in the Federal Register on
November 6, 2009, (74 FR 57522), ISP
Freetown Fine Chemicals, 238 South
Main Street, Assonet, Massachusetts
02702, made application by renewal to
the Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of the basic classes of
controlled substances listed in
schedules I and II:
By Notice dated October 16, 2009, and
published in the Federal Register on
October 28, 2009, (74 FR 55587),
Cayman Chemical Company, 1180 East
Ellsworth Road, Ann Arbor, Michigan
48108, made application by renewal to
the Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of the basic classes of
controlled substances listed in schedule
I:
Drug
Schedule
2,5–Dimethoxyamphetamine
(7396) ........................................
Amphetamine (1100) ....................
Methylphenidate (1724) ................
Phenylacetone (8501) ..................
Dextropropoxyphene, bulk (nondosage forms) (9273) ...............
16:08 Mar 02, 2010
Marihuana (7360) .........................
Tetrahydrocannabinols (7370) ......
Dated: February 25, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2010–4400 Filed 3–2–10; 8:45 am]
Dated: February 24, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
BILLING CODE 4410–09–P
[FR Doc. 2010–4401 Filed 3–2–10; 8:45 am]
BILLING CODE 4410–09–P
Jkt 220001
Schedule
I
I
The company plans to manufacture
small quantities of marihuana
II derivatives for research purposes.
In reference to drug code 7360
(Marihuana), the company plans to bulk
The company plans to manufacture
manufacture cannabidiol. In reference to
bulk API, for distribution to its
drug code 7370
customers. The bulk 2,5–
(Tetrahydrocannabinols), the company
Dimethoxyamphetamine will be used
will manufacture a synthetic THC. No
for conversion into non-controlled
other activity for this drug code is
substances.
authorized for this registration.
No comments or objections have been
No comments or objections have been
received. DEA has considered the
factors in 21 USC 823(a) and determined received. DEA has considered the
factors in 21 U.S.C. 823(a) and
that the registration of ISP Freetown
determined that the registration of
Fine Chemicals to manufacture the
Cayman Chemical Company to
listed basic classes of controlled
substances is consistent with the public manufacture the listed basic classes of
controlled substances is consistent with
interest at this time. DEA has
the public interest at this time. DEA has
investigated ISP Freetown Fine
Chemicals to ensure that the company’s investigated Cayman Chemical
registration is consistent with the public Company to ensure that the company’s
interest. The investigation has included registration is consistent with the public
inspection and testing of the company’s interest. The investigation has included
inspection and testing of the company’s
physical security systems, verification
of the company’s compliance with state physical security systems, verification
of the company’s compliance with state
and local laws, and a review of the
and local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 USC 823, and company’s background and history.
in accordance with 21 CFR 1301.33, the Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
above named company is granted
the above named company is granted
registration as a bulk manufacturer of
registration as a bulk manufacturer of
the basic classes of controlled
the basic classes of controlled
substances listed.
substances listed.
BILLING CODE 4410–09–P
VerDate Nov<24>2008
I
II
II
II
Drug
PO 00000
Frm 00043
Fmt 4703
Sfmt 9990
E:\FR\FM\03MRN1.SGM
03MRN1
]]>Agencies
[Federal Register Volume 75, Number 41 (Wednesday, March 3, 2010)]
[Notices]
[Page 9614]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-4401]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated October 16, 2009, and published in the Federal
Register on October 28, 2009, (74 FR 55587), Cayman Chemical Company,
1180 East Ellsworth Road, Ann Arbor, Michigan 48108, made application
by renewal to the Drug Enforcement Administration (DEA) to be
registered as a bulk manufacturer of the basic classes of controlled
substances listed in schedule I:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Marihuana (7360)............................................. I
Tetrahydrocannabinols (7370)................................. I
------------------------------------------------------------------------
The company plans to manufacture small quantities of marihuana
derivatives for research purposes.
In reference to drug code 7360 (Marihuana), the company plans to
bulk manufacture cannabidiol. In reference to drug code 7370
(Tetrahydrocannabinols), the company will manufacture a synthetic THC.
No other activity for this drug code is authorized for this
registration.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
Cayman Chemical Company to manufacture the listed basic classes of
controlled substances is consistent with the public interest at this
time. DEA has investigated Cayman Chemical Company to ensure that the
company's registration is consistent with the public interest. The
investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance
with state and local laws, and a review of the company's background and
history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with
21 CFR 1301.33, the above named company is granted registration as a
bulk manufacturer of the basic classes of controlled substances listed.
Dated: February 24, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2010-4401 Filed 3-2-10; 8:45 am]
BILLING CODE 4410-09-P
